Financhill
Back

Halozyme Therapeutics Vs. TransMedics Group Industry Stock Comparison

Buy
51

HALO
Halozyme Therapeutics

Last Price:
$46.95
Seasonality Move:
7.09%
Sell
41

TMDX
TransMedics Group

Last Price:
$61.77
Seasonality Move:
32.05%
Buy
51
Halozyme Therapeutics (HALO) is a Buy

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $46.93. The Score for HALO is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
  • HALO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
41
TransMedics Group (TMDX) is a Sell

Is TransMedics Group a Buy, Sell or Hold?

  • The current TransMedics Group [TMDX] share price is $61.74. The Score for TMDX is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • TMDX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $46.93
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

TMDX Stock Price Chart

What is TransMedics Group's stock price today?

  • The TransMedics Group share price today is $61.74
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TMDX is experiencing slight buying pressure.

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.11 Sell
Relative Strength Index (14 RSI): 40.79 Sell
Chaikin Money Flow: -4132103 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (45.97 - 48.99) Sell
Bollinger Bands (100): (49.23 - 60.41) Sell

TMDX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -8.13 Sell
Relative Strength Index (14 RSI): 30.68 Sell
Chaikin Money Flow: 722215 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (64.59 - 81.21) Sell
Bollinger Bands (100): (84.78 - 160.08) Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 47.62 Sell
20-day SMA: 48.12 Sell
50-day SMA: 51 Sell
200-day SMA: 50.14 Sell
8-day EMA: 47.61 Sell
20-day EMA: 48.45 Sell
50-day EMA: 50.73 Sell
200-day EMA: 50.06 Sell

TMDX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 63.8 Sell
20-day SMA: 71.08 Sell
50-day SMA: 89.56 Sell
200-day SMA: 120.56 Sell
8-day EMA: 64.03 Sell
20-day EMA: 70.61 Sell
50-day EMA: 88.62 Sell
200-day EMA: 110.03 Sell

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.56 per share.

TransMedics Group Earnings Growth & TMDX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.53 per share, and an increase next year of $0.45 per share.

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

TransMedics Group Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):